Trial Profile

TapERA: Maintaining remission in RA while tapering Etanercept

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 24 Jan 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Etanercept (Primary)
Indications Rheumatoid arthritis
Focus Therapeutic Use
Acronyms TapERA

Most Recent Events

01 Jan 2023 Results assessing Validation and predictive capacity of a Dutch version of the FLARE-RA questionnaire within the context of a TNFi-tapering trial published in the Clinical Rheumatology
05 Jun 2021 Results (n=66) of post-hoc analysis assessing patient perceived aspects of Ra flare by the Flare-Ra Questionnaire, presented at the 22nd Annual Congress of the European League Against Rheumatism
06 Jun 2020 Results from patients included in TapERA trial were used to assess if the Flare-Ra Questionnaire can identify omeract flares in Patients with Rheumatoid Arthritis, presented at the 21st Annual Congress of the European League Against Rheumatism

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com